REGULATORY INTELLIGENCE·Recall
Perrigo's Nationwide Recall of Oxymetazoline HCl: Contaminated Excipient Exposes Critical CGMP Failures
Perrigo Company PLC initiated a Class II recall (D-0623-2022) of 1,560 bottles of Oxymetazoline HCl 0.05% nasal spray due to CGMP deviations involving a contaminated excipient. This terminated nationwide recall highlights critical supplier quality control failures, posing significant risks for procurement and regulatory teams reliant on robust raw material vetting. Businesses must scrutinize excipient supply chains to mitigate similar disruptions and ensure product integrity.
90-Day Activity